Barclays PLC reports 3.88% stake in Archimedes
Barclays PLC filed an amended Schedule 13G to report its beneficial ownership in Archimedes Tech SPAC Partner common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Barclays PLC filed an amended Schedule 13G to report its beneficial ownership in Archimedes Tech SPAC Partner common stock. Barclays reports beneficial ownership of 1,148,590 common shares, representing 3.88% of the outstanding class as of the reported date.
Barclays states it has sole voting and sole dispositive power over all 1,148,590 shares, with no shared voting or dispositive power. The filing confirms that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Barclays PLC report in this Schedule 13G/A for ATII?
What percentage of ATII’s common stock is held by Barclays PLC?
Is Barclays PLC seeking control of Archimedes Tech SPAC Partner?
AI-generated analysis. How Rhea-AI works. Not financial advice.